Skip to main content

Table 1 Characteristics of Studies Included in the Meta-Analysis

From: Is topiramate effective for migraine prevention in patients less than 18 years of age? A meta-analysis of randomized controlled trials

First authors, year

Diagnostic tool

Topiramate

Placebo

N

Age (years),mean ± SD

Gender

(male:female,%)

Dose& Duration

Side effects/Adverse events

N

Age (years),mean ± SD

Gender (male: female,%)

Titration

Maintenance

Paul Winner,2005

International Headache Society (IHS) diagnostic criteria for pediatric migraine

108

11.3 ± 2.5

50.9:49.1

8-week:

Week 1 = 15 mg/d

Week 2 = 30 mg/d

Week 3 = 50 mg/d

(dose increased to 2–3 mg/kg/d)

12-week: 2–3 mg/kg/d

upper respiratory tract infection, anorexia, weight decrease, gastroenteritis, paresthesia, somnolence

49

10.7 ± 2.6

53.1:46.9

C. V. S. Lakshmi,2007

International Classification of Headache Disorders, 2nd Edition (ICHD-II)

21

10.95 ± 1.53

85.7:14.3

1-month: 25-mg incremented to 100 mg/d

3-month: 100 mg/d

weight loss, lack of concentration in school, parasthesia, sedation, loss of appetite, pain in abdomen

21

10.14 ± 1.35

52.4:47.6

Donald Lewis,2009

International Classification of Headache Disorders, 2nd Edition (ICHD-II)

70

14.2 ± 1.54

40:60

4-week: 25-mg incremented to 50 or 100 mg/d

12-week: 50 or 100 mg/d

upper respiratory tract infection, paresthesia, abdominal pain, anorexia, injury, rhinitis, coughing, viral infection, pharyngitis, fatigue, nausea, dizziness, taste perversion, insomnia, back pain, conjunctivitis, sinusitis, asthma, pneumonia, fever, allergy, vomiting, nervousness, somnolence, abnormal vision, eye pain

33

14.4 ± 1.7

36:64

Scott W.Powers,2017a

International Classification of Headache Disorders, 2nd Edition (ICHD-II)

145

14.2 ± 2.5

30:70

8-week: 2 mg/Kg.d, dose escalation occurred every 2 weeks

16-week: average 1.93 ± 0.40 mg mg/Kg.d

aphasia, cognitive disorder, dizziness, memory impairment, paresthesia, general: fatigue, dry mouth, intussusception, streptococcal pharyngitis, upper respiratory tract infection, altered mood, suicide attempt, investigations: decreased weight, contusion, traumatic liver injury, respiratory: bronchospasm

33

14.2 ± 2.2

32:68

  1. SD standard deviations, N Total number in group
  2. aThe analysis population included patients who ended trial early
  3. †35 subjects treated with topiramate at 50 mg/day, 35 subjects treated with topiramate at 100 mg/day